Centaurus Financial’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,545
| Closed | -$117K | – | 903 |
|
|
2021
Q4 | $117K | Sell |
1,545
-500
| -24% | -$37.9K | 0.01% | 842 |
|
|
2021
Q3 | $229K | Buy |
2,045
+200
| +11% | +$22.4K | 0.02% | 614 |
|
|
2021
Q2 | $299K | Sell |
1,845
-200
| -10% | -$32.4K | 0.03% | 569 |
|
|
2021
Q1 | $249K | Buy |
2,045
+492
| +32% | +$59.9K | 0.02% | 547 |
|
|
2020
Q4 | $238K | Buy |
+1,553
| New | +$238K | 0.03% | 513 |
|
|
2018
Q3 | – | Sell |
-281
| Closed | -$17K | – | 824 |
|
|
2018
Q2 | $17K | Buy |
+281
| New | +$17K | ﹤0.01% | 1336 |
|